Yeditepe University Hospitals Infectious Diseases and Clinical Microbiology Specialist Prof. Dr. Meral Sönmezoğlu made an important statement due to World Hepatitis Day, stating that 290 million people live without knowing that they have hepatitis.
Stating that viral hepatitis is one of the most important health problems worldwide, Prof. Dr. Sönmezoğlu said, "Although hepatitis is a preventable, recognizable, treatable, and even completely eliminable disease, the increase in loss of life due to this reason in recent years draws attention. Although awareness studies have been carried out under the leadership of the World Health Organization, unfortunately, the disease is still not sufficiently recognized. Viral hepatitis B and C, which are also the main causes of liver cancer, affect 325 million people worldwide. Since it can continue for many years without any symptoms, it can lead to liver cancer and cirrhosis. More importantly, 9 out of 10 people with viral hepatitis live without knowing that they have hepatitis B or C. The World Health Organization continues its awareness efforts to prevent this picture by cooperating with all segments of society with the slogan "Find the Missing Millions". It is aimed to reach 30 percent of those who are unaware of their disease by 2020.
Stating that the hepatitis B virus is transmitted by contact with infected blood or body fluids, Prof. Dr. Sönmezoğlu explained that the frequency of transmission varies according to geographical region and said: "The mode of transmission differs according to geographical regions. In Western European countries, for example, most infections are transmitted by sexual contact with the infected person or by sharing needles and syringes. In Asia and the Middle East, it is usually passed from mother to child or from child to child. Other common contaminants include the common use of personal items such as toothbrushes and razor blades with infected individuals and the use of unsterilized tools for tattooing and piercing."
Stating that the period of newborn and infancy is shown as the period with the highest risk of carrier and chronic hepatitis, Prof. Dr. Sönmezoğlu said, "With the hepatitis B vaccine, it is possible to achieve effective results in preventing the disease. However, there are still 3 and a half million hepatitis B patients in Türkiye. Since 1998, all newborns and those in the risk group have been given a free hepatitis B vaccine by the Ministry of Health. While the number of people infected with this vaccination program in 2000 was around 12 percent, today it has decreased to 4 percent. With the continuation of vaccination, it will be possible to prevent hepatitis D as well as reduce the rate of hepatitis B".
Stating that combined use of needles and syringes, blood transfusions with contaminated blood, or organ transplants from infected people, and hepatitis C can occur at the rate of mother-to-child transmission, Prof. Dr. Sönmezoğlu: "The most common form of transmission in Türkiye is not fully known. After 1996, all blood was screened for hepatitis C, which significantly reduced blood transmission. Although there is no effective vaccine for hepatitis C yet, it should not be forgotten that it has an effective treatment. Almost all patients can be treated with early diagnosis. However, it is estimated that there are approximately 800,000 hepatitis C patients in Türkiye. Hepatitis A virus is also one of the most common causes of acute viral hepatitis in the world. This virus, which is moderately common in Türkiye, can cause epidemics with mostly dirty, contaminated water and nutrients. While it can be passed with mild symptoms in childhood, it is possible to be protected with the vaccine from hepatitis A infection, which can be more severe in advanced ages and cause consequences that can lead to severe liver disease."
”
Alo Yeditepe